Combined PEG liposomal doxorubicin and gemcitabine are active and have acceptable toxicity in patients with platinum-refractory and -resistant ovarian cancer after previous platinumtaxane therapy:A phase Ⅱ Austrian AGO study

查看全文 作　　者：Petru E;Angleitner-Boubenizek L;Reinthaller A; 出　　处：《Gynecol Oncol》索引2006年第102卷第2期,共0页